ClinicalTrials.gg
Sign In

Latent Tuberculosis clinical trials

The registry lists 199 studies for Latent Tuberculosis across more than 10 countries. 48 are recruiting or about to start. 153 of them are mainly about Latent Tuberculosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Latent Tuberculosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
87
Status unknown
34
Recruiting
29
Not yet recruiting
16
Active, not recruiting
13
Terminated
9

Phase

Phase 3
21
Phase 4
18
Phase 2
17
Phase 1
15
Early Phase 1
2

Where

United States
28
South Africa
20
United Kingdom
13
Korea, Republic of
12
China
12
Spain
11

Who runs them

National Taiwan University Hospital (8) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · Johns Hopkins University (6) · Centers for Disease Control and Prevention (5) · Queen Mary University of London (5) · McGill University Health Centre/Research Institute of the McGill University Health Centre (4) · Instituto Nacional de Salud Publica, Mexico (4) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (4)

What is being tested here

Drugs under test in Latent Tuberculosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rifapentine6614
Isoniazid3420
Rifampin227
Bedaquiline123
Levofloxacin123
Ainuovirine101
Lamivudine101
Tenofovir101
Dolutegravir101
Chloroquine101

Coming up

5phase 3 studies under way
24studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 29 Latent Tuberculosis studies recruiting now, 15 (52%) set no upper age limit and 12 (41%) stop at 75 or younger. 15 (52%) take children under 18. 1 (3%) are for women only and 0 (0%) for men only; 7 (24%) take healthy volunteers.

Recruiting studies that take each age, of 29
AgeWomenMen
1010 (34%)10 (34%)
1823 (79%)22 (76%)
3022 (76%)21 (72%)
4022 (76%)21 (72%)
5022 (76%)21 (72%)
6520 (69%)19 (66%)
7517 (59%)16 (55%)
8517 (59%)16 (55%)

Across all 199 studies, recruiting or not: 33% stop at 75 or younger and 29% at 65; 36% take children; 4% are for women only and 2% for men only; 38% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Latent Tuberculosis studies take

Of 31 observational studies under Latent Tuberculosis, half reached primary completion within 94 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase32 mo17–47 · 30 studies——
Observational94 mo37–98 · 31 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 199. Browse all 199 → or search them.